nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2D6—Niacin—atherosclerosis	0.0637	0.106	CbGbCtD
Donepezil—CYP2C9—Rosuvastatin—atherosclerosis	0.0592	0.099	CbGbCtD
Donepezil—CYP2C9—Simvastatin—atherosclerosis	0.055	0.092	CbGbCtD
Donepezil—CYP2C9—Pravastatin—atherosclerosis	0.0538	0.0901	CbGbCtD
Donepezil—CYP2C9—Lovastatin—atherosclerosis	0.0538	0.0901	CbGbCtD
Donepezil—CYP2D6—Simvastatin—atherosclerosis	0.0503	0.0842	CbGbCtD
Donepezil—CYP2D6—Pravastatin—atherosclerosis	0.0492	0.0824	CbGbCtD
Donepezil—CYP2D6—Lovastatin—atherosclerosis	0.0492	0.0824	CbGbCtD
Donepezil—CYP3A4—Ezetimibe—atherosclerosis	0.0344	0.0576	CbGbCtD
Donepezil—CYP3A4—Rosuvastatin—atherosclerosis	0.0344	0.0576	CbGbCtD
Donepezil—CYP3A4—Simvastatin—atherosclerosis	0.032	0.0535	CbGbCtD
Donepezil—CYP3A4—Pravastatin—atherosclerosis	0.0313	0.0524	CbGbCtD
Donepezil—CYP3A4—Lovastatin—atherosclerosis	0.0313	0.0524	CbGbCtD
Donepezil—HTR2A—arteriole—atherosclerosis	0.00319	0.27	CbGeAlD
Donepezil—Moexipril—ACE—atherosclerosis	0.00192	1	CrCbGaD
Donepezil—HTR2A—vein—atherosclerosis	0.0019	0.161	CbGeAlD
Donepezil—HTR2A—hindlimb—atherosclerosis	0.00126	0.107	CbGeAlD
Donepezil—HTR2A—appendage—atherosclerosis	0.00109	0.0918	CbGeAlD
Donepezil—HTR2A—artery—atherosclerosis	0.000775	0.0656	CbGeAlD
Donepezil—HTR2A—endothelium—atherosclerosis	0.000655	0.0554	CbGeAlD
Donepezil—HTR2A—blood vessel—atherosclerosis	0.000604	0.0511	CbGeAlD
Donepezil—Muscle spasms—Lovastatin—atherosclerosis	0.000483	0.00178	CcSEcCtD
Donepezil—Infection—Rosuvastatin—atherosclerosis	0.000481	0.00177	CcSEcCtD
Donepezil—Visual impairment—Niacin—atherosclerosis	0.000478	0.00176	CcSEcCtD
Donepezil—Alopecia—Simvastatin—atherosclerosis	0.000477	0.00175	CcSEcCtD
Donepezil—Back pain—Ezetimibe—atherosclerosis	0.000477	0.00175	CcSEcCtD
Donepezil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000474	0.00175	CcSEcCtD
Donepezil—Muscle spasms—Ezetimibe—atherosclerosis	0.000474	0.00174	CcSEcCtD
Donepezil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000474	0.00174	CcSEcCtD
Donepezil—Vision blurred—Lovastatin—atherosclerosis	0.000473	0.00174	CcSEcCtD
Donepezil—Mental disorder—Simvastatin—atherosclerosis	0.000473	0.00174	CcSEcCtD
Donepezil—Tremor—Lovastatin—atherosclerosis	0.000471	0.00173	CcSEcCtD
Donepezil—Visual impairment—Pravastatin—atherosclerosis	0.00047	0.00173	CcSEcCtD
Donepezil—Erythema—Simvastatin—atherosclerosis	0.00047	0.00173	CcSEcCtD
Donepezil—Ill-defined disorder—Lovastatin—atherosclerosis	0.000466	0.00171	CcSEcCtD
Donepezil—Flatulence—Simvastatin—atherosclerosis	0.000463	0.0017	CcSEcCtD
Donepezil—Tinnitus—Niacin—atherosclerosis	0.000462	0.0017	CcSEcCtD
Donepezil—Dysgeusia—Simvastatin—atherosclerosis	0.00046	0.00169	CcSEcCtD
Donepezil—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000457	0.00168	CcSEcCtD
Donepezil—Anaemia—Ezetimibe—atherosclerosis	0.000455	0.00168	CcSEcCtD
Donepezil—Tinnitus—Pravastatin—atherosclerosis	0.000455	0.00167	CcSEcCtD
Donepezil—Malaise—Lovastatin—atherosclerosis	0.000453	0.00167	CcSEcCtD
Donepezil—Muscle spasms—Simvastatin—atherosclerosis	0.000452	0.00166	CcSEcCtD
Donepezil—Vertigo—Lovastatin—atherosclerosis	0.000451	0.00166	CcSEcCtD
Donepezil—SIGMAR1—adipose tissue—atherosclerosis	0.000446	0.0377	CbGeAlD
Donepezil—Chills—Niacin—atherosclerosis	0.000445	0.00164	CcSEcCtD
Donepezil—Malaise—Ezetimibe—atherosclerosis	0.000444	0.00163	CcSEcCtD
Donepezil—Vision blurred—Simvastatin—atherosclerosis	0.000443	0.00163	CcSEcCtD
Donepezil—Arrhythmia—Niacin—atherosclerosis	0.000443	0.00163	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000441	0.00162	CcSEcCtD
Donepezil—Tremor—Simvastatin—atherosclerosis	0.00044	0.00162	CcSEcCtD
Donepezil—Alopecia—Niacin—atherosclerosis	0.000438	0.00161	CcSEcCtD
Donepezil—Chills—Pravastatin—atherosclerosis	0.000438	0.00161	CcSEcCtD
Donepezil—Insomnia—Rosuvastatin—atherosclerosis	0.000438	0.00161	CcSEcCtD
Donepezil—Ill-defined disorder—Simvastatin—atherosclerosis	0.000436	0.0016	CcSEcCtD
Donepezil—Arrhythmia—Pravastatin—atherosclerosis	0.000436	0.0016	CcSEcCtD
Donepezil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000434	0.0016	CcSEcCtD
Donepezil—Anaemia—Simvastatin—atherosclerosis	0.000434	0.0016	CcSEcCtD
Donepezil—Erythema—Niacin—atherosclerosis	0.000431	0.00159	CcSEcCtD
Donepezil—Malnutrition—Niacin—atherosclerosis	0.000431	0.00159	CcSEcCtD
Donepezil—Alopecia—Pravastatin—atherosclerosis	0.000431	0.00159	CcSEcCtD
Donepezil—Cough—Ezetimibe—atherosclerosis	0.00043	0.00158	CcSEcCtD
Donepezil—Myalgia—Lovastatin—atherosclerosis	0.000428	0.00157	CcSEcCtD
Donepezil—Chest pain—Lovastatin—atherosclerosis	0.000428	0.00157	CcSEcCtD
Donepezil—Arthralgia—Lovastatin—atherosclerosis	0.000428	0.00157	CcSEcCtD
Donepezil—Anxiety—Lovastatin—atherosclerosis	0.000426	0.00157	CcSEcCtD
Donepezil—Dyspepsia—Rosuvastatin—atherosclerosis	0.000426	0.00157	CcSEcCtD
Donepezil—Hypertension—Ezetimibe—atherosclerosis	0.000425	0.00157	CcSEcCtD
Donepezil—Flatulence—Niacin—atherosclerosis	0.000425	0.00156	CcSEcCtD
Donepezil—Malaise—Simvastatin—atherosclerosis	0.000424	0.00156	CcSEcCtD
Donepezil—Tension—Niacin—atherosclerosis	0.000423	0.00156	CcSEcCtD
Donepezil—Discomfort—Lovastatin—atherosclerosis	0.000423	0.00155	CcSEcCtD
Donepezil—Vertigo—Simvastatin—atherosclerosis	0.000422	0.00155	CcSEcCtD
Donepezil—Chest pain—Ezetimibe—atherosclerosis	0.000419	0.00154	CcSEcCtD
Donepezil—Myalgia—Ezetimibe—atherosclerosis	0.000419	0.00154	CcSEcCtD
Donepezil—Arthralgia—Ezetimibe—atherosclerosis	0.000419	0.00154	CcSEcCtD
Donepezil—Nervousness—Niacin—atherosclerosis	0.000419	0.00154	CcSEcCtD
Donepezil—Flatulence—Pravastatin—atherosclerosis	0.000419	0.00154	CcSEcCtD
Donepezil—Dry mouth—Lovastatin—atherosclerosis	0.000418	0.00154	CcSEcCtD
Donepezil—Tension—Pravastatin—atherosclerosis	0.000417	0.00153	CcSEcCtD
Donepezil—Dysgeusia—Pravastatin—atherosclerosis	0.000416	0.00153	CcSEcCtD
Donepezil—Muscle spasms—Niacin—atherosclerosis	0.000415	0.00153	CcSEcCtD
Donepezil—Discomfort—Ezetimibe—atherosclerosis	0.000414	0.00152	CcSEcCtD
Donepezil—Constipation—Rosuvastatin—atherosclerosis	0.000414	0.00152	CcSEcCtD
Donepezil—Pain—Rosuvastatin—atherosclerosis	0.000414	0.00152	CcSEcCtD
Donepezil—Confusional state—Lovastatin—atherosclerosis	0.000413	0.00152	CcSEcCtD
Donepezil—Nervousness—Pravastatin—atherosclerosis	0.000413	0.00152	CcSEcCtD
Donepezil—Dry mouth—Ezetimibe—atherosclerosis	0.00041	0.00151	CcSEcCtD
Donepezil—Muscle spasms—Pravastatin—atherosclerosis	0.000408	0.0015	CcSEcCtD
Donepezil—Infection—Lovastatin—atherosclerosis	0.000407	0.0015	CcSEcCtD
Donepezil—Vision blurred—Niacin—atherosclerosis	0.000407	0.0015	CcSEcCtD
Donepezil—Confusional state—Ezetimibe—atherosclerosis	0.000405	0.00149	CcSEcCtD
Donepezil—Thrombocytopenia—Lovastatin—atherosclerosis	0.000401	0.00148	CcSEcCtD
Donepezil—Vision blurred—Pravastatin—atherosclerosis	0.0004	0.00147	CcSEcCtD
Donepezil—Arthralgia—Simvastatin—atherosclerosis	0.0004	0.00147	CcSEcCtD
Donepezil—Chest pain—Simvastatin—atherosclerosis	0.0004	0.00147	CcSEcCtD
Donepezil—Myalgia—Simvastatin—atherosclerosis	0.0004	0.00147	CcSEcCtD
Donepezil—Infection—Ezetimibe—atherosclerosis	0.000399	0.00147	CcSEcCtD
Donepezil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000399	0.00147	CcSEcCtD
Donepezil—Anxiety—Simvastatin—atherosclerosis	0.000399	0.00147	CcSEcCtD
Donepezil—Tremor—Pravastatin—atherosclerosis	0.000398	0.00146	CcSEcCtD
Donepezil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000396	0.00146	CcSEcCtD
Donepezil—Discomfort—Simvastatin—atherosclerosis	0.000395	0.00145	CcSEcCtD
Donepezil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000394	0.00145	CcSEcCtD
Donepezil—Ill-defined disorder—Pravastatin—atherosclerosis	0.000394	0.00145	CcSEcCtD
Donepezil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000394	0.00145	CcSEcCtD
Donepezil—Anaemia—Pravastatin—atherosclerosis	0.000393	0.00144	CcSEcCtD
Donepezil—Anorexia—Lovastatin—atherosclerosis	0.000391	0.00144	CcSEcCtD
Donepezil—Vertigo—Niacin—atherosclerosis	0.000388	0.00143	CcSEcCtD
Donepezil—Syncope—Niacin—atherosclerosis	0.000387	0.00142	CcSEcCtD
Donepezil—Confusional state—Simvastatin—atherosclerosis	0.000387	0.00142	CcSEcCtD
Donepezil—Urticaria—Rosuvastatin—atherosclerosis	0.000384	0.00141	CcSEcCtD
Donepezil—Oedema—Simvastatin—atherosclerosis	0.000383	0.00141	CcSEcCtD
Donepezil—Malaise—Pravastatin—atherosclerosis	0.000383	0.00141	CcSEcCtD
Donepezil—Abdominal pain—Rosuvastatin—atherosclerosis	0.000382	0.00141	CcSEcCtD
Donepezil—Vertigo—Pravastatin—atherosclerosis	0.000382	0.0014	CcSEcCtD
Donepezil—Infection—Simvastatin—atherosclerosis	0.000381	0.0014	CcSEcCtD
Donepezil—Loss of consciousness—Niacin—atherosclerosis	0.000379	0.0014	CcSEcCtD
Donepezil—Cough—Niacin—atherosclerosis	0.000376	0.00139	CcSEcCtD
Donepezil—Thrombocytopenia—Simvastatin—atherosclerosis	0.000375	0.00138	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000373	0.00137	CcSEcCtD
Donepezil—Insomnia—Lovastatin—atherosclerosis	0.000371	0.00136	CcSEcCtD
Donepezil—Cough—Pravastatin—atherosclerosis	0.000371	0.00136	CcSEcCtD
Donepezil—Paraesthesia—Lovastatin—atherosclerosis	0.000368	0.00135	CcSEcCtD
Donepezil—Myalgia—Niacin—atherosclerosis	0.000367	0.00135	CcSEcCtD
Donepezil—Arthralgia—Niacin—atherosclerosis	0.000367	0.00135	CcSEcCtD
Donepezil—Hypertension—Pravastatin—atherosclerosis	0.000367	0.00135	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000366	0.00135	CcSEcCtD
Donepezil—Anorexia—Simvastatin—atherosclerosis	0.000366	0.00134	CcSEcCtD
Donepezil—Dyspnoea—Lovastatin—atherosclerosis	0.000365	0.00134	CcSEcCtD
Donepezil—Insomnia—Ezetimibe—atherosclerosis	0.000364	0.00134	CcSEcCtD
Donepezil—Myalgia—Pravastatin—atherosclerosis	0.000362	0.00133	CcSEcCtD
Donepezil—Chest pain—Pravastatin—atherosclerosis	0.000362	0.00133	CcSEcCtD
Donepezil—Arthralgia—Pravastatin—atherosclerosis	0.000362	0.00133	CcSEcCtD
Donepezil—Paraesthesia—Ezetimibe—atherosclerosis	0.000361	0.00133	CcSEcCtD
Donepezil—Dyspepsia—Lovastatin—atherosclerosis	0.000361	0.00133	CcSEcCtD
Donepezil—Anxiety—Pravastatin—atherosclerosis	0.00036	0.00133	CcSEcCtD
Donepezil—Dry mouth—Niacin—atherosclerosis	0.000359	0.00132	CcSEcCtD
Donepezil—Dyspnoea—Ezetimibe—atherosclerosis	0.000358	0.00132	CcSEcCtD
Donepezil—Discomfort—Pravastatin—atherosclerosis	0.000357	0.00131	CcSEcCtD
Donepezil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000356	0.00131	CcSEcCtD
Donepezil—Decreased appetite—Lovastatin—atherosclerosis	0.000356	0.00131	CcSEcCtD
Donepezil—Dyspepsia—Ezetimibe—atherosclerosis	0.000354	0.0013	CcSEcCtD
Donepezil—Fatigue—Lovastatin—atherosclerosis	0.000353	0.0013	CcSEcCtD
Donepezil—Oedema—Niacin—atherosclerosis	0.000352	0.0013	CcSEcCtD
Donepezil—Pain—Lovastatin—atherosclerosis	0.000351	0.00129	CcSEcCtD
Donepezil—Constipation—Lovastatin—atherosclerosis	0.000351	0.00129	CcSEcCtD
Donepezil—Confusional state—Pravastatin—atherosclerosis	0.00035	0.00129	CcSEcCtD
Donepezil—Decreased appetite—Ezetimibe—atherosclerosis	0.00035	0.00129	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000349	0.00129	CcSEcCtD
Donepezil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000347	0.00128	CcSEcCtD
Donepezil—Asthenia—Rosuvastatin—atherosclerosis	0.000347	0.00128	CcSEcCtD
Donepezil—Insomnia—Simvastatin—atherosclerosis	0.000347	0.00128	CcSEcCtD
Donepezil—Oedema—Pravastatin—atherosclerosis	0.000347	0.00128	CcSEcCtD
Donepezil—Fatigue—Ezetimibe—atherosclerosis	0.000347	0.00128	CcSEcCtD
Donepezil—Shock—Niacin—atherosclerosis	0.000346	0.00127	CcSEcCtD
Donepezil—Infection—Pravastatin—atherosclerosis	0.000344	0.00127	CcSEcCtD
Donepezil—Paraesthesia—Simvastatin—atherosclerosis	0.000344	0.00127	CcSEcCtD
Donepezil—Pain—Ezetimibe—atherosclerosis	0.000344	0.00127	CcSEcCtD
Donepezil—Constipation—Ezetimibe—atherosclerosis	0.000344	0.00127	CcSEcCtD
Donepezil—Pruritus—Rosuvastatin—atherosclerosis	0.000342	0.00126	CcSEcCtD
Donepezil—Dyspnoea—Simvastatin—atherosclerosis	0.000342	0.00126	CcSEcCtD
Donepezil—Hyperhidrosis—Niacin—atherosclerosis	0.00034	0.00125	CcSEcCtD
Donepezil—Thrombocytopenia—Pravastatin—atherosclerosis	0.000339	0.00125	CcSEcCtD
Donepezil—Feeling abnormal—Lovastatin—atherosclerosis	0.000338	0.00124	CcSEcCtD
Donepezil—Dyspepsia—Simvastatin—atherosclerosis	0.000338	0.00124	CcSEcCtD
Donepezil—Anorexia—Niacin—atherosclerosis	0.000336	0.00123	CcSEcCtD
Donepezil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000335	0.00123	CcSEcCtD
Donepezil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000335	0.00123	CcSEcCtD
Donepezil—Decreased appetite—Simvastatin—atherosclerosis	0.000333	0.00123	CcSEcCtD
Donepezil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000331	0.00122	CcSEcCtD
Donepezil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000331	0.00122	CcSEcCtD
Donepezil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000331	0.00122	CcSEcCtD
Donepezil—Fatigue—Simvastatin—atherosclerosis	0.000331	0.00122	CcSEcCtD
Donepezil—Anorexia—Pravastatin—atherosclerosis	0.00033	0.00122	CcSEcCtD
Donepezil—Hypotension—Niacin—atherosclerosis	0.000329	0.00121	CcSEcCtD
Donepezil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000329	0.00121	CcSEcCtD
Donepezil—Pain—Simvastatin—atherosclerosis	0.000328	0.00121	CcSEcCtD
Donepezil—Constipation—Simvastatin—atherosclerosis	0.000328	0.00121	CcSEcCtD
Donepezil—CYP2C9—cardiovascular system—atherosclerosis	0.000327	0.0277	CbGeAlD
Donepezil—Urticaria—Lovastatin—atherosclerosis	0.000326	0.0012	CcSEcCtD
Donepezil—Abdominal pain—Lovastatin—atherosclerosis	0.000324	0.00119	CcSEcCtD
Donepezil—Body temperature increased—Lovastatin—atherosclerosis	0.000324	0.00119	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000321	0.00118	CcSEcCtD
Donepezil—Dizziness—Rosuvastatin—atherosclerosis	0.00032	0.00118	CcSEcCtD
Donepezil—Urticaria—Ezetimibe—atherosclerosis	0.000319	0.00118	CcSEcCtD
Donepezil—Insomnia—Niacin—atherosclerosis	0.000318	0.00117	CcSEcCtD
Donepezil—Body temperature increased—Ezetimibe—atherosclerosis	0.000318	0.00117	CcSEcCtD
Donepezil—Abdominal pain—Ezetimibe—atherosclerosis	0.000318	0.00117	CcSEcCtD
Donepezil—Paraesthesia—Niacin—atherosclerosis	0.000316	0.00116	CcSEcCtD
Donepezil—Feeling abnormal—Simvastatin—atherosclerosis	0.000316	0.00116	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000316	0.00116	CcSEcCtD
Donepezil—Dyspnoea—Niacin—atherosclerosis	0.000314	0.00115	CcSEcCtD
Donepezil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000314	0.00115	CcSEcCtD
Donepezil—Insomnia—Pravastatin—atherosclerosis	0.000314	0.00115	CcSEcCtD
Donepezil—Somnolence—Niacin—atherosclerosis	0.000313	0.00115	CcSEcCtD
Donepezil—SIGMAR1—liver—atherosclerosis	0.000313	0.0265	CbGeAlD
Donepezil—Paraesthesia—Pravastatin—atherosclerosis	0.000311	0.00115	CcSEcCtD
Donepezil—Dyspepsia—Niacin—atherosclerosis	0.00031	0.00114	CcSEcCtD
Donepezil—HTR2A—connective tissue—atherosclerosis	0.00031	0.0262	CbGeAlD
Donepezil—Dyspnoea—Pravastatin—atherosclerosis	0.000309	0.00114	CcSEcCtD
Donepezil—Decreased appetite—Niacin—atherosclerosis	0.000306	0.00113	CcSEcCtD
Donepezil—Dyspepsia—Pravastatin—atherosclerosis	0.000305	0.00112	CcSEcCtD
Donepezil—Rash—Rosuvastatin—atherosclerosis	0.000305	0.00112	CcSEcCtD
Donepezil—Dermatitis—Rosuvastatin—atherosclerosis	0.000305	0.00112	CcSEcCtD
Donepezil—Urticaria—Simvastatin—atherosclerosis	0.000305	0.00112	CcSEcCtD
Donepezil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000304	0.00112	CcSEcCtD
Donepezil—Abdominal pain—Simvastatin—atherosclerosis	0.000303	0.00112	CcSEcCtD
Donepezil—Body temperature increased—Simvastatin—atherosclerosis	0.000303	0.00112	CcSEcCtD
Donepezil—Headache—Rosuvastatin—atherosclerosis	0.000303	0.00112	CcSEcCtD
Donepezil—Hypersensitivity—Lovastatin—atherosclerosis	0.000302	0.00111	CcSEcCtD
Donepezil—Decreased appetite—Pravastatin—atherosclerosis	0.000301	0.00111	CcSEcCtD
Donepezil—Pain—Niacin—atherosclerosis	0.000301	0.00111	CcSEcCtD
Donepezil—Fatigue—Pravastatin—atherosclerosis	0.000299	0.0011	CcSEcCtD
Donepezil—Pain—Pravastatin—atherosclerosis	0.000296	0.00109	CcSEcCtD
Donepezil—Constipation—Pravastatin—atherosclerosis	0.000296	0.00109	CcSEcCtD
Donepezil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000296	0.00109	CcSEcCtD
Donepezil—Asthenia—Lovastatin—atherosclerosis	0.000294	0.00108	CcSEcCtD
Donepezil—Pruritus—Lovastatin—atherosclerosis	0.00029	0.00107	CcSEcCtD
Donepezil—Asthenia—Ezetimibe—atherosclerosis	0.000288	0.00106	CcSEcCtD
Donepezil—Gastrointestinal pain—Niacin—atherosclerosis	0.000288	0.00106	CcSEcCtD
Donepezil—Nausea—Rosuvastatin—atherosclerosis	0.000287	0.00106	CcSEcCtD
Donepezil—Feeling abnormal—Pravastatin—atherosclerosis	0.000286	0.00105	CcSEcCtD
Donepezil—Pruritus—Ezetimibe—atherosclerosis	0.000284	0.00105	CcSEcCtD
Donepezil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000283	0.00104	CcSEcCtD
Donepezil—Hypersensitivity—Simvastatin—atherosclerosis	0.000283	0.00104	CcSEcCtD
Donepezil—Diarrhoea—Lovastatin—atherosclerosis	0.00028	0.00103	CcSEcCtD
Donepezil—Urticaria—Niacin—atherosclerosis	0.00028	0.00103	CcSEcCtD
Donepezil—Abdominal pain—Niacin—atherosclerosis	0.000278	0.00102	CcSEcCtD
Donepezil—Body temperature increased—Niacin—atherosclerosis	0.000278	0.00102	CcSEcCtD
Donepezil—Urticaria—Pravastatin—atherosclerosis	0.000275	0.00101	CcSEcCtD
Donepezil—Asthenia—Simvastatin—atherosclerosis	0.000275	0.00101	CcSEcCtD
Donepezil—Diarrhoea—Ezetimibe—atherosclerosis	0.000275	0.00101	CcSEcCtD
Donepezil—Body temperature increased—Pravastatin—atherosclerosis	0.000274	0.00101	CcSEcCtD
Donepezil—Abdominal pain—Pravastatin—atherosclerosis	0.000274	0.00101	CcSEcCtD
Donepezil—Pruritus—Simvastatin—atherosclerosis	0.000271	0.000998	CcSEcCtD
Donepezil—Dizziness—Lovastatin—atherosclerosis	0.000271	0.000997	CcSEcCtD
Donepezil—HTR2A—cardiovascular system—atherosclerosis	0.000269	0.0228	CbGeAlD
Donepezil—Dizziness—Ezetimibe—atherosclerosis	0.000266	0.000978	CcSEcCtD
Donepezil—Diarrhoea—Simvastatin—atherosclerosis	0.000262	0.000965	CcSEcCtD
Donepezil—Vomiting—Lovastatin—atherosclerosis	0.000261	0.000959	CcSEcCtD
Donepezil—Hypersensitivity—Niacin—atherosclerosis	0.000259	0.000954	CcSEcCtD
Donepezil—Rash—Lovastatin—atherosclerosis	0.000258	0.000951	CcSEcCtD
Donepezil—Dermatitis—Lovastatin—atherosclerosis	0.000258	0.00095	CcSEcCtD
Donepezil—Headache—Lovastatin—atherosclerosis	0.000257	0.000945	CcSEcCtD
Donepezil—Vomiting—Ezetimibe—atherosclerosis	0.000256	0.000941	CcSEcCtD
Donepezil—Hypersensitivity—Pravastatin—atherosclerosis	0.000255	0.00094	CcSEcCtD
Donepezil—Dizziness—Simvastatin—atherosclerosis	0.000254	0.000933	CcSEcCtD
Donepezil—Rash—Ezetimibe—atherosclerosis	0.000254	0.000933	CcSEcCtD
Donepezil—Dermatitis—Ezetimibe—atherosclerosis	0.000253	0.000932	CcSEcCtD
Donepezil—Asthenia—Niacin—atherosclerosis	0.000253	0.000929	CcSEcCtD
Donepezil—Headache—Ezetimibe—atherosclerosis	0.000252	0.000927	CcSEcCtD
Donepezil—Pruritus—Niacin—atherosclerosis	0.000249	0.000917	CcSEcCtD
Donepezil—Asthenia—Pravastatin—atherosclerosis	0.000249	0.000915	CcSEcCtD
Donepezil—Pruritus—Pravastatin—atherosclerosis	0.000245	0.000902	CcSEcCtD
Donepezil—Vomiting—Simvastatin—atherosclerosis	0.000244	0.000897	CcSEcCtD
Donepezil—Nausea—Lovastatin—atherosclerosis	0.000244	0.000896	CcSEcCtD
Donepezil—Rash—Simvastatin—atherosclerosis	0.000242	0.00089	CcSEcCtD
Donepezil—Dermatitis—Simvastatin—atherosclerosis	0.000242	0.000889	CcSEcCtD
Donepezil—Diarrhoea—Niacin—atherosclerosis	0.000241	0.000886	CcSEcCtD
Donepezil—Headache—Simvastatin—atherosclerosis	0.00024	0.000884	CcSEcCtD
Donepezil—Nausea—Ezetimibe—atherosclerosis	0.000239	0.000879	CcSEcCtD
Donepezil—Diarrhoea—Pravastatin—atherosclerosis	0.000237	0.000873	CcSEcCtD
Donepezil—Dizziness—Niacin—atherosclerosis	0.000233	0.000857	CcSEcCtD
Donepezil—Dizziness—Pravastatin—atherosclerosis	0.000229	0.000843	CcSEcCtD
Donepezil—Nausea—Simvastatin—atherosclerosis	0.000228	0.000838	CcSEcCtD
Donepezil—Vomiting—Niacin—atherosclerosis	0.000224	0.000824	CcSEcCtD
Donepezil—Rash—Niacin—atherosclerosis	0.000222	0.000817	CcSEcCtD
Donepezil—Dermatitis—Niacin—atherosclerosis	0.000222	0.000816	CcSEcCtD
Donepezil—Headache—Niacin—atherosclerosis	0.000221	0.000812	CcSEcCtD
Donepezil—Vomiting—Pravastatin—atherosclerosis	0.00022	0.000811	CcSEcCtD
Donepezil—Rash—Pravastatin—atherosclerosis	0.000219	0.000804	CcSEcCtD
Donepezil—Dermatitis—Pravastatin—atherosclerosis	0.000218	0.000804	CcSEcCtD
Donepezil—Headache—Pravastatin—atherosclerosis	0.000217	0.000799	CcSEcCtD
Donepezil—Nausea—Niacin—atherosclerosis	0.000209	0.00077	CcSEcCtD
Donepezil—Nausea—Pravastatin—atherosclerosis	0.000206	0.000758	CcSEcCtD
Donepezil—CYP2C9—liver—atherosclerosis	0.000202	0.0171	CbGeAlD
Donepezil—HTR2A—liver—atherosclerosis	0.000167	0.0141	CbGeAlD
Donepezil—CYP3A4—liver—atherosclerosis	0.000154	0.0131	CbGeAlD
Donepezil—CYP2D6—liver—atherosclerosis	0.000152	0.0128	CbGeAlD
Donepezil—HTR2A—Signaling Pathways—CX3CL1—atherosclerosis	3e-05	0.000257	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.99e-05	0.000256	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—EDN1—atherosclerosis	2.97e-05	0.000255	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.96e-05	0.000254	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCL5—atherosclerosis	2.95e-05	0.000253	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOS3—atherosclerosis	2.93e-05	0.000252	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—atherosclerosis	2.92e-05	0.000251	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	2.89e-05	0.000248	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLTP—atherosclerosis	2.85e-05	0.000244	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CNR2—atherosclerosis	2.84e-05	0.000244	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—atherosclerosis	2.84e-05	0.000244	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MMP3—atherosclerosis	2.84e-05	0.000243	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.83e-05	0.000243	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FABP4—atherosclerosis	2.81e-05	0.000241	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LCAT—atherosclerosis	2.81e-05	0.000241	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PRKCG—atherosclerosis	2.8e-05	0.00024	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOB—atherosclerosis	2.8e-05	0.00024	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FABP4—atherosclerosis	2.78e-05	0.000239	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LCAT—atherosclerosis	2.78e-05	0.000239	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA4—atherosclerosis	2.76e-05	0.000236	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA4—atherosclerosis	2.73e-05	0.000234	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—atherosclerosis	2.72e-05	0.000234	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.71e-05	0.000232	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	2.7e-05	0.000231	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.68e-05	0.00023	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	2.68e-05	0.00023	CbGpPWpGaD
Donepezil—ACHE—Metabolism—LPL—atherosclerosis	2.67e-05	0.000229	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX1—atherosclerosis	2.61e-05	0.000224	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—atherosclerosis	2.6e-05	0.000223	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.56e-05	0.000219	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	2.55e-05	0.000218	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CD36—atherosclerosis	2.54e-05	0.000218	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VWF—atherosclerosis	2.54e-05	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOC3—atherosclerosis	2.52e-05	0.000216	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—atherosclerosis	2.51e-05	0.000216	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LDLR—atherosclerosis	2.5e-05	0.000215	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.5e-05	0.000214	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.48e-05	0.000213	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—atherosclerosis	2.48e-05	0.000212	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.47e-05	0.000212	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.47e-05	0.000212	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	2.47e-05	0.000212	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL3—atherosclerosis	2.45e-05	0.00021	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.44e-05	0.000209	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTHFR—atherosclerosis	2.41e-05	0.000206	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.38e-05	0.000204	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.37e-05	0.000203	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA2—atherosclerosis	2.37e-05	0.000203	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.37e-05	0.000203	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.37e-05	0.000203	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARA—atherosclerosis	2.36e-05	0.000203	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—atherosclerosis	2.35e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA2—atherosclerosis	2.35e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.35e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.35e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.35e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.34e-05	0.000201	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCF1—atherosclerosis	2.34e-05	0.000201	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NFKB1—atherosclerosis	2.33e-05	0.0002	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.32e-05	0.000199	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.32e-05	0.000199	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK8—atherosclerosis	2.29e-05	0.000196	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AGT—atherosclerosis	2.29e-05	0.000196	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—atherosclerosis	2.28e-05	0.000196	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—F2—atherosclerosis	2.28e-05	0.000195	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LPA—atherosclerosis	2.26e-05	0.000194	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LPA—atherosclerosis	2.24e-05	0.000192	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—atherosclerosis	2.24e-05	0.000192	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGT—atherosclerosis	2.24e-05	0.000192	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAV1—atherosclerosis	2.22e-05	0.00019	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOA1—atherosclerosis	2.22e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR2—atherosclerosis	2.21e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	2.21e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CYBA—atherosclerosis	2.2e-05	0.000189	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BGN—atherosclerosis	2.19e-05	0.000188	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	2.18e-05	0.000187	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BGN—atherosclerosis	2.17e-05	0.000186	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA5—atherosclerosis	2.17e-05	0.000186	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.16e-05	0.000185	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLAT—atherosclerosis	2.16e-05	0.000185	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GHRL—atherosclerosis	2.16e-05	0.000185	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PARP1—atherosclerosis	2.16e-05	0.000185	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA5—atherosclerosis	2.15e-05	0.000184	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—atherosclerosis	2.11e-05	0.000181	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—atherosclerosis	2.09e-05	0.000179	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.09e-05	0.000179	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.09e-05	0.000179	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—F2—atherosclerosis	2.07e-05	0.000177	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.07e-05	0.000177	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.05e-05	0.000175	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.03e-05	0.000174	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.02e-05	0.000173	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—atherosclerosis	2.02e-05	0.000173	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.02e-05	0.000173	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK3—atherosclerosis	2e-05	0.000171	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALOX5—atherosclerosis	2e-05	0.000171	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	1.98e-05	0.00017	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—atherosclerosis	1.95e-05	0.000167	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.95e-05	0.000167	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—atherosclerosis	1.94e-05	0.000166	CbGpPWpGaD
Donepezil—ACHE—Metabolism—INS—atherosclerosis	1.91e-05	0.000164	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KNG1—atherosclerosis	1.89e-05	0.000162	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	1.88e-05	0.000161	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.85e-05	0.000158	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	1.85e-05	0.000158	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LCAT—atherosclerosis	1.84e-05	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FABP4—atherosclerosis	1.84e-05	0.000157	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLG—atherosclerosis	1.83e-05	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.81e-05	0.000155	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA4—atherosclerosis	1.8e-05	0.000154	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LIPC—atherosclerosis	1.8e-05	0.000154	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.79e-05	0.000154	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOC3—atherosclerosis	1.79e-05	0.000153	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.78e-05	0.000153	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LIPC—atherosclerosis	1.78e-05	0.000153	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LDLR—atherosclerosis	1.78e-05	0.000152	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOC3—atherosclerosis	1.77e-05	0.000152	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.77e-05	0.000152	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LDLR—atherosclerosis	1.76e-05	0.000151	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—atherosclerosis	1.76e-05	0.000151	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	1.74e-05	0.000149	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CETP—atherosclerosis	1.73e-05	0.000149	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CETP—atherosclerosis	1.72e-05	0.000147	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—atherosclerosis	1.68e-05	0.000144	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP3—atherosclerosis	1.68e-05	0.000144	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF2—atherosclerosis	1.67e-05	0.000143	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.66e-05	0.000142	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.65e-05	0.000141	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.64e-05	0.00014	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOB—atherosclerosis	1.62e-05	0.000139	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.61e-05	0.000138	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.6e-05	0.000137	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—atherosclerosis	1.59e-05	0.000137	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL5—atherosclerosis	1.58e-05	0.000136	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.57e-05	0.000134	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA2—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LPL—atherosclerosis	1.55e-05	0.000133	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—atherosclerosis	1.54e-05	0.000132	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.53e-05	0.000131	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	1.5e-05	0.000129	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPA—atherosclerosis	1.48e-05	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SPP1—atherosclerosis	1.47e-05	0.000126	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—atherosclerosis	1.46e-05	0.000125	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	1.46e-05	0.000125	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BGN—atherosclerosis	1.43e-05	0.000123	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA5—atherosclerosis	1.42e-05	0.000122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.4e-05	0.00012	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.4e-05	0.00012	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.39e-05	0.000119	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.37e-05	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	1.36e-05	0.000116	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—atherosclerosis	1.35e-05	0.000116	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGT—atherosclerosis	1.32e-05	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.32e-05	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—atherosclerosis	1.3e-05	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LEP—atherosclerosis	1.3e-05	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CAV1—atherosclerosis	1.28e-05	0.00011	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOA1—atherosclerosis	1.28e-05	0.00011	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—atherosclerosis	1.24e-05	0.000106	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—F2—atherosclerosis	1.22e-05	0.000105	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.2e-05	0.000103	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.19e-05	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.000101	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LIPC—atherosclerosis	1.18e-05	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	1.17e-05	0.0001	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOC3—atherosclerosis	1.17e-05	0.0001	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LDLR—atherosclerosis	1.16e-05	9.95e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOB—atherosclerosis	1.15e-05	9.85e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOB—atherosclerosis	1.14e-05	9.76e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CETP—atherosclerosis	1.13e-05	9.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	1.12e-05	9.61e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.12e-05	9.58e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—INS—atherosclerosis	1.11e-05	9.5e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.11e-05	9.5e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LPL—atherosclerosis	1.1e-05	9.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—atherosclerosis	1.09e-05	9.35e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LPL—atherosclerosis	1.09e-05	9.32e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.09e-05	9.31e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—atherosclerosis	1.07e-05	9.19e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—atherosclerosis	1.07e-05	9.17e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—atherosclerosis	1.06e-05	9.1e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD36—atherosclerosis	1.04e-05	8.94e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD36—atherosclerosis	1.03e-05	8.86e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.03e-05	8.79e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	1.02e-05	8.72e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.88e-06	8.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—atherosclerosis	9.79e-06	8.39e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—atherosclerosis	9.71e-06	8.33e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARA—atherosclerosis	9.69e-06	8.31e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARA—atherosclerosis	9.6e-06	8.24e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AGT—atherosclerosis	9.38e-06	8.05e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AGT—atherosclerosis	9.3e-06	7.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—atherosclerosis	9.19e-06	7.88e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.14e-06	7.84e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—atherosclerosis	9.11e-06	7.81e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAV1—atherosclerosis	9.11e-06	7.81e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA1—atherosclerosis	9.09e-06	7.79e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAV1—atherosclerosis	9.03e-06	7.74e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA1—atherosclerosis	9.01e-06	7.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	8.62e-06	7.39e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	8.32e-06	7.14e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.3e-06	7.11e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	8.23e-06	7.05e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—atherosclerosis	8.19e-06	7.03e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—atherosclerosis	8.01e-06	6.87e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—atherosclerosis	7.94e-06	6.81e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—INS—atherosclerosis	7.85e-06	6.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.84e-06	6.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—atherosclerosis	7.79e-06	6.68e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—INS—atherosclerosis	7.79e-06	6.68e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—atherosclerosis	7.72e-06	6.62e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	7.71e-06	6.61e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	7.58e-06	6.5e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	7.56e-06	6.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOB—atherosclerosis	7.51e-06	6.44e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.31e-06	6.26e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—atherosclerosis	7.2e-06	6.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPL—atherosclerosis	7.17e-06	6.15e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—atherosclerosis	7.14e-06	6.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	7e-06	6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—atherosclerosis	7e-06	6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—atherosclerosis	6.93e-06	5.94e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—atherosclerosis	6.89e-06	5.91e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—atherosclerosis	6.83e-06	5.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD36—atherosclerosis	6.81e-06	5.84e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	6.62e-06	5.68e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.46e-06	5.54e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	6.42e-06	5.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARA—atherosclerosis	6.33e-06	5.43e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.3e-06	5.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.25e-06	5.35e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGT—atherosclerosis	6.13e-06	5.26e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—atherosclerosis	6.01e-06	5.15e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAV1—atherosclerosis	5.96e-06	5.11e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA1—atherosclerosis	5.94e-06	5.09e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.42e-06	4.65e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—atherosclerosis	5.24e-06	4.49e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—INS—atherosclerosis	5.14e-06	4.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—atherosclerosis	4.84e-06	4.15e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—atherosclerosis	4.71e-06	4.04e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—atherosclerosis	4.5e-06	3.86e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—atherosclerosis	4.47e-06	3.83e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.12e-06	3.53e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—atherosclerosis	3.17e-06	2.71e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—atherosclerosis	3.14e-06	2.69e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—atherosclerosis	2.07e-06	1.77e-05	CbGpPWpGaD
